GSK PEG: current value, 10-year range and year-by-year history
Cash & Leverage
GSK's peg is higher than 95% of the last 10 years.
PEG History
GSK PEG by year
Yearly range of GSK’s peg from 2019 to 2026. Over the full period it ranged from 0.1 to 11.4, averaging 2.4.
| Year | Low | Average | High | Year-end |
|---|---|---|---|---|
| 2026 | 7.5 | 9.3 | 11.4 | 10.4 |
| 2024 | 2.2 | 5.0 | 8.1 | 6.8 |
| 2023 | 0.1 | 0.1 | 0.4 | 0.4 |
| 2022 | 0.1 | 0.5 | 0.9 | 0.1 |
| 2021 | 0.1 | 0.2 | 0.4 | 0.4 |
| 2020 | 1.1 | 1.4 | 1.5 | 1.3 |
| 2019 | 1.5 | 10.2 | 10.9 | 1.5 |
Get notified when GSK PEG crosses a threshold
Free — one alert setup, notifications by push, Telegram, or Discord.
P/E ratio divided by the earnings growth rate. Peter Lynch's tool for checking whether a higher P/E is actually justified by faster growth. PEG ≤ 1.0 is Lynch's "fairly priced" threshold.
P/E Ratio / Annual EPS Growth Rate (%)A low PEG vs the stock's own history suggests the market may not be fully pricing in the growth rate — the combination of P/E and growth looks unusually attractive.
- Only meaningful for businesses with real, consistent earnings growth. Irrelevant for cyclicals, early-stage companies, and income stocks.
- Forward PEG is based on analyst estimates that are frequently optimistic — treat it as a sanity check, not a primary signal.
Is GSK PEG High or Low Right Now?
GSK plc's PEG is currently 10.4, which is near historic high relative to its 10-year historical range. The 10-year median PEG for GSK is approximately 0.5. See all GSK valuation metrics →
Unlock 10y, 15y, 20y, and 30y history with peer comparison and CSV export.